Premier Biomedical, Inc.
BIEI
Get informed when a big investor buys or sells
+ FollowMarket Cap$909.99K
Close$
$-0.00
185.7% downside
Current Fair Value
185.7% downsideOvervalued by 185.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $909,986.00 |
|---|---|
| Enterprise Value | $1.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.8 |
| Outstanding Shares | 1,649,880,958 |
Return
| Return on Equity | 2.04% |
|---|---|
| Return on Assets | -110.47% |
| Return on Invested Capital | 2.04% |
Valuation & Multiples
| P/E Ratio | -22.01 |
|---|---|
| PEG | 10.39 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 28.3 |
| Enterprise Value to EBIT | -31.44 |
| Enterprise Value to Net Income | -32 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | -0.29 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Premier Biomedical, Inc.
4 employees
CEO: Ivan Mendez Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extrac...